NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

immatics biotechnologies GmbH 

Paul-Ehrlich-Strasse 15

Tuebingen    D-72076  Germany
Phone: 49-7071-565125-0 Fax: 49-7071-565125-99


SEARCH JOBS










 Company News
immatics biotechnologies GmbH Significantly Improves XPRESIDENT(TM) Technology Platform 6/17/2009 11:35:46 AM    More...
immatics biotechnologies GmbH Completes Patient Recruitment In Phase II Study With Cancer Vaccine IMA901 For Renal Cell Cancer 3/3/2009 12:53:50 PM    More...
immatics biotechnologies GmbH Wins 29th German Industry's Innovation Award 1/26/2009 1:43:03 PM    More...
immatics biotechnologies GmbH Obtains Important U.S. and European Patents 7/14/2008 11:38:03 AM    More...
immatics biotechnologies GmbH Appoints Paul G. Higham as Chief Executive Officer 7/9/2008 9:09:10 AM    More...
immatics biotechnologies GmbH Receives 3 Research Grants Totaling 1.4 mn € to Advance its Early-Stage Cancer Immunotherapy Programs 7/7/2008 1:10:40 PM    More...
immatics biotechnologies GmbH Granted Orphan Drug Status for Therapeutic Cancer Vaccine IMA901 3/14/2007 4:36:32 PM    More...
immatics biotechnologies GmbH Receives 40 Million Eur In Second Round Of Cancer Treatment Funding 2/8/2007 11:36:21 AM    More...
immatics biotechnologies GmbH Succesfully Concludes Phase 1 Clinical Study On Potential Renal Cell Cancer Vaccine 10/10/2006 2:32:14 PM    More...
immatics biotechnologies GmbH And responsif GmbH Sign A Cooperation Agreement Within The Scope Of The BioChancePLUS Grant Program 5/22/2006 2:30:07 PM    More...